Director of Oncology
Bon Animal Medical Center
Suwon, Kyonggi-do, Republic of Korea
Dr. Doyun Kim, DVM, PhD, is a clinician-scientist in veterinary oncology with a research focus on targeted therapies in dogs and cats.
He has published a prospective clinical study evaluating sorafenib in dogs with advanced carcinomas in Veterinary and Comparative Oncology and has conducted a clinical study of lapatinib in dogs with metastatic mammary gland tumors.
His work explores the integration of clinical outcomes with biomarker-based approaches to inform treatment strategies in clinical oncology practice.
Disclosure(s): CaniCatiCare: Advisor (Ongoing); IDEXX Laboratories: Advisor (Ongoing); PODO Therapeutics: Advisor (Ongoing)
Transitioning from Tyrosine Kinase Inhibitors to Precision Oncology
Saturday, June 13, 2026
8:00 AM - 9:00 AM PT